Tomoyuki Naito

Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden

Tomoyuki Naito, Hibiki Udagawa, Shigeki Umemura et al. · Lung Cancer · 2019 · 100 citations

Oncology, Medicine, Swi/snf Complex +12

Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report

Tomoyuki Naito, Shigeki Umemura, Hiroshi Nakamura et al. · Thoracic Cancer · 2019 · 96 citations · Full text

Feasibility and utility of transbronchial cryobiopsy in precision medicine for lung cancer: Prospective single‐arm study

Hibiki Udagawa, Keisuke Kirita, Tomoyuki Naito et al. · Cancer Science · 2020 · 70 citations · Full text

A Minimum Of 100 Tumor Cells in a Single Biopsy Sample Is Required to Assess Programmed Cell Death Ligand 1 Expression in Predicting Patient Response to Nivolumab Treatment in Nonsquamous Non–Small Cell Lung Carcinoma

Tomoyuki Naito, Hibiki Udagawa, Jun Sato et al. · Journal of Thoracic Oncology · 2019 · 32 citations

Nivolumab Treatment, Medicine, Pathology +10

Secretion of high amounts of hepatocyte growth factor is a characteristic feature of cancer‐associated fibroblasts with EGFR‐TKI resistance‐promoting phenotype: A study of 18 cases of cancer‐associated fibroblasts

Érika Suzuki, Shota Yamazaki, Tomoyuki Naito et al. · Pathology International · 2019 · 21 citations